Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays

由 Gupta, Yash, Maciorowski, Dawid, Zak, Samantha E., Jones, Krysten A., Kathayat, Rahul S., Azizi, Saara-Anne, Mathur, Raman, Pearce, Catherine M, Ilc, David J., Husein, Hamza, Herbert, Andrew S., Bharti, Ajay, Rathi, Brijesh, Durvasula, Ravi, Becker, Daniel P., Dickinson, Bryan C., Dye, John M., Kempaiah, Prakasha
發表在 Methods (2021)